BridgeMD
New treatment option for No-Reflow
Official title No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
ClinicalTrials.gov ID: NCT06966674
What this study is testing
What is Intracoronary tirofiban?
Intracoronary tirofiban is an investigational medicine, being studied as a potential treatment for no-reflow.
Also referred to as Aggrastat.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years old.
- Both sexes.
- Patients with STEMI. ST-segment elevated myocardial infarction is defined as typical chest pain \>30 minutes with ST-segment elevation of \>1 mm in...
You likely can't join if
- Treatment with thrombolytic drugs in the previous 24 hours.
- Known malignancy.
- Thrombocytopenia.
- End-stage liver disease.
- Cardiogenic shock.
- Renal failure with glomerular filtration\<30 ml/min.
See the full eligibility criteria
- Age ≥ 18 years old.
- Both sexes.
- Patients with STEMI. ST-segment elevated myocardial infarction is defined as typical chest pain \>30 minutes with ST-segment elevation of \>1 mm in at least 2 consecutive leads on the electrocardiogram or new-onset left...
- Treatment with thrombolytic drugs in the previous 24 hours.
- Known malignancy.
- Thrombocytopenia.
- End-stage liver disease.
- Cardiogenic shock.
- Renal failure with glomerular filtration\<30 ml/min.
- Contraindication for the use of tirofiban.
The study team makes the final eligibility decision.
Where it's taking place
- Kafr ash Shaykh, Kafrelsheikh, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kafr ash Shaykh, Kafrelsheikh, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.